Community-Acquired, Post-COVID-19, Methicillin-Resistant Staphylococcus aureus Pneumonia and Empyema

Area of Science:

• Infectious Diseases
• Pulmonology
• Critical Care Medicine

Background:

• The COVID-19 pandemic has led to increased secondary infections, particularly nosocomial ones.
• Bacterial pneumonia is a significant complication in hospitalized COVID-19 patients.
• Multidrug-resistant organisms pose a growing threat in healthcare settings.

Observation:

• A 77-year-old male presented with multifocal pneumonia and right-sided empyema four weeks after initial COVID-19 diagnosis.
• The infection was caused by methicillin-resistant Staphylococcus aureus (MRSA).
• The patient required chest tube thoracostomy, intrapleural fibrinolysis, and eventually video-assisted thoracoscopy with decortication.

Findings:

• This case represents a rare instance of community-acquired MRSA lung infection post-COVID-19 recovery.
• MRSA empyema following COVID-19 pneumonia necessitates aggressive management.
• Successful treatment involved a combination of surgical intervention and targeted antibiotics.

Implications:

• Highlights the importance of vigilant monitoring for secondary infections in COVID-19 patients.
• Underscores the potential severity and diverse manifestations of opportunistic infections post-COVID-19.
• Emphasizes the need for comprehensive strategies to combat multidrug-resistant organisms in the context of viral pandemics.